Skip to content
Home/Companies/Biotech/Sophia Genetics
Sophia Genetics

Sophia Genetics

Biotech·Switzerland·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Sophia Genetics?

Sophia Genetics is currently owned by Eurazeo through Eurazeo Growth Fund III (2019 vintage), since 2019. Across its history, Sophia Genetics has been through 4 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Eurazeo
Most recent investor
Eurazeo
Eurazeo Growth Fund III · 2019 · Growth
4 ownership periods · full history below

Key facts

HQSwitzerland
SectorBiotech
Key takeaways
  • ·Held by Eurazeo since 2019 (7Y hold).
  • ·Average hold across 3 realized cycles: 3 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Active
Currently held by Eurazeo since 2019.
Co-invest · 4 holders · 2014 · present
360 Capital Partners
2014 · 2021(7yr) · 360 Capital 2011 · 2011 · VC
IPO
MOIC
Balderton Capital
2019 · 2021(2yr) · Balderton Capital VII · 2019 · VC
IPO
MOIC
Eurazeo
EurazeoActive
2019 · present(7yr) · Eurazeo Growth Fund III · 2019 · Growth
Hitachi Ventures
Hitachi VenturesExited 2021
2020 · 2021(1yr) · Hitachi Ventures Fund I · 2019 · VC
IPO
MOIC
Track Sophia Genetics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sophia Genetics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sophia Genetics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue